Zobrazeno 1 - 10
of 109
pro vyhledávání: '"Marco Filetti"'
Autor:
Marco Filetti, Pasquale Lombardi, Rosa Falcone, Raffaele Giusti, Diana Giannarelli, Antonella Carcagnì, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 6, Pp 1136-1144 (2023)
Aim: This article is based on our previous research, which was presented as a post at the Congress Aiom 2022 Congress and published in Tumori Journal as Conference Abstract (Tumori J. 2022;108:1–194. doi: 10.1177/03008916221114500). In this paper,
Externí odkaz:
https://doaj.org/article/f446b3071a6f42da9738270bbed6e743
Autor:
Rosa Falcone, Marco Filetti, Pasquale Lombardi, Valeria Altamura, Francesco Paroni Sterbini, Giovanni Scambia, Gennaro Daniele
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 4, Iss 4, Pp 716-726 (2023)
Aim: AT-rich interaction domain 1A (ARID1A) encodes a key component of the SWItch/Sucrose Non-Fermentable (SWI/SNF) chromatin remodeling complex that participates in gene expression. ARID1A alterations are quite common among cancer patients, although
Externí odkaz:
https://doaj.org/article/332642ff24084277bee380049cb3eabb
Publikováno v:
Computer Methods and Programs in Biomedicine Update, Vol 5, Iss , Pp 100157- (2024)
Externí odkaz:
https://doaj.org/article/cde2983aba7c49cda77121f4a2183eb4
Autor:
Rosa Falcone, Pasquale Lombardi, Marco Filetti, Alessandra Fabi, Valeria Altamura, Giovanni Scambia, Gennaro Daniele
Publikováno v:
Current Oncology, Vol 30, Iss 2, Pp 2501-2509 (2023)
(1) Background: Precision oncology is opening new treatment opportunities for patients suffering from solid tumors. In the last two decades, the advent of CDK4/6 inhibitors, immunotherapy, and antibody–drug conjugates (ADC) improved survival outcom
Externí odkaz:
https://doaj.org/article/8063d1e652d5445e80e1bd5d418bc2cd
Autor:
Alessio Cortellini, Raffaele Giusti, Marco Filetti, Fabrizio Citarella, Vincenzo Adamo, Daniele Santini, Sebastiano Buti, Olga Nigro, Luca Cantini, Massimo Di Maio, Joachim G. J. V. Aerts, Emilio Bria, Federica Bertolini, Miriam Grazia Ferrara, Michele Ghidini, Francesco Grossi, Annalisa Guida, Rossana Berardi, Alessandro Morabito, Carlo Genova, Francesca Mazzoni, Lorenzo Antonuzzo, Alain Gelibter, Paolo Marchetti, Rita Chiari, Marianna Macerelli, Francesca Rastelli, Luigi Della Gravara, Stefania Gori, Alessandro Tuzi, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Pecci, Federica Zoratto, Serena Ricciardi, Maria Rita Migliorino, Francesco Passiglia, Giulio Metro, Gian Paolo Spinelli, Giuseppe L. Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio, Marcello Tiseo, Marco Russano, Alessandro Russo, David James Pinato
Publikováno v:
Journal of Hematology & Oncology, Vol 15, Iss 1, Pp 1-6 (2022)
Abstract Family history of cancer (FHC) is a hallmark of cancer risk and an independent predictor of outcome, albeit with uncertain biologic foundations. We previously showed that FHC-high patients experienced prolonged overall (OS) and progression-f
Externí odkaz:
https://doaj.org/article/ef36c449c9224564a2852f68941a9276
Autor:
Daniele Santini, Tea Zeppola, Marco Russano, Fabrizio Citarella, Cecilia Anesi, Sebastiano Buti, Marco Tucci, Alessandro Russo, Maria Chiara Sergi, Vincenzo Adamo, Luigia S. Stucci, Melissa Bersanelli, Giulia Mazzaschi, Francesco Spagnolo, Francesca Rastelli, Francesca Chiara Giorgi, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Alain Gelibter, Marco Siringo, Marco Ferrari, Riccardo Marconcini, Maria Giuseppa Vitale, Linda Nicolardi, Rita Chiari, Michele Ghidini, Olga Nigro, Francesco Grossi, Michele De Tursi, Pietro Di Marino, Laura Pala, Paola Queirolo, Sergio Bracarda, Serena Macrini, Stefania Gori, Alessandro Inno, Federica Zoratto, Enrica T. Tanda, Domenico Mallardo, Maria Grazia Vitale, Thomas Talbot, Paolo A. Ascierto, David J. Pinato, Corrado Ficorella, Giampiero Porzio, Alessio Cortellini
Publikováno v:
Journal of Translational Medicine, Vol 19, Iss 1, Pp 1-8 (2021)
Abstract Background The favourable safety profile and the increasing confidence with immune checkpoint inhibitors (ICIs) might have boosted their prescription in frail patients with short life expectancies, who usually are not treated with standard c
Externí odkaz:
https://doaj.org/article/6d89e6884a4e4f16873bdd6d6f5f5956
Autor:
Alessio Cortellini, Andrea De Giglio, Katia Cannita, Diego L. Cortinovis, Robin Cornelissen, Cinzia Baldessari, Raffaele Giusti, Ettore D'Argento, Francesco Grossi, Matteo Santoni, Annamaria Catino, Rossana Berardi, Vincenzo Sforza, Giovanni Rossi, Lorenzo Antonuzzo, Vincenzo Di Noia, Diego Signorelli, Alain Gelibter, Mario Alberto Occhipinti, Alessandro Follador, Francesca Rastelli, Rita Chiari, Luigi Della Gravara, Alessandro Inno, Michele De Tursi, Pietro Di Marino, Giovanni Mansueto, Federica Zoratto, Marco Filetti, Michele Montrone, Fabrizio Citarella, Maria Vittoria Pensieri, Marco Russano, Luca Cantini, Olga Nigro, Alessandro Leonetti, Paola Bordi, Gabriele Minuti, Lorenza Landi, Alessandro De Toma, Clelia Donisi, Serena Ricciardi, Maria Rita Migliorino, Valerio Maria Napoli, Gianmarco Leone, Giulio Metro, Giuseppe L. Banna, Alex Friedlaender, Alfredo Addeo, Corrado Ficorella, Giampiero Porzio
Publikováno v:
Thoracic Cancer, Vol 12, Iss 6, Pp 880-889 (2021)
Abstract Background Improved outcome in tobacco smoking patients with non‐small cell lung cancer (NSCLC) following immunotherapy has previously been reported. However, little is known regarding this association during first‐line immunotherapy in
Externí odkaz:
https://doaj.org/article/c7f53a01da6942bfa7ce73222085c5cd
Autor:
Marta Zerunian, Damiano Caruso, Alberto Zucchelli, Michela Polici, Carlo Capalbo, Marco Filetti, Federica Mazzuca, Paolo Marchetti, Andrea Laghi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-10 (2021)
Abstract Clinical evaluation poorly predicts outcomes in lung cancer treated with immunotherapy. The aim of the study is to assess whether CT-derived texture parameters can predict overall survival (OS) and progression-free survival (PFS) in patients
Externí odkaz:
https://doaj.org/article/18a7ae47de7d4a85ad1c5f7dd80511e2
Autor:
Abdul Rafeh Naqash, Shravanti Macherla, Alessio Cortellini, Melissa Bersanelli, Sebastiano Buti, Raffaele Giusti, Marco Filetti, Paolo Marchetti, Andrea Botticelli, Domenico Mallardo, Thomas Marron, Douglas Johnson, Christopher Hoimes, Vito Vanella, Toni Choueiri, Paolo Ascierto, Ella Daniels, Haocan Song, Fei Ye, Tamara Sussman, Domenico Galetta, Anwaar Saeed, Annamaria Catino, Carlo Genova, Pamela Pizzutilo, Giuseppe Lamberti, David Pinato, Rebecca Irlmeier, Caroline Nebhan, Weijie Ma, Teja Ganta, Neha Debnath, Maluki Radford, Asrar Alahmadi, Akiva Diamond, Nikhil Ramaiya, Carolyn Presley, Dwight Owen, Sarah Abou Alaiwi, Amin Nassar, Chiara Casartelli, Maria Giovanna Dal Bello, Foteini Kalofonou
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss Suppl 2 (2021)
Externí odkaz:
https://doaj.org/article/d3d2c8bfadc44b14b83c47b19f5d8ab6
Autor:
Alessandro Rossi, Marco Filetti, Beatrice Taurelli Salimbeni, Marta Piras, Francesco Rizzo, Raffaele Giusti, Paolo Marchetti
Publikováno v:
Cancer Reports, Vol 4, Iss 4, Pp n/a-n/a (2021)
Abstract Background Recent researches suggested that statins, beside their role in inhibiting endogenous cholesterol synthesis and in cardiovascular prevention, could influence several processes in cancer biology. In fact, a recent meta‐analysis de
Externí odkaz:
https://doaj.org/article/457f76ceb4b14d04a9c26a2114c3fd69